US Stock MarketDetailed Quotes

Alzamend Neuro (ALZN)

Watchlist
  • 2.350
  • +0.100+4.44%
Close Jan 16 16:00 ET
  • 2.350
  • 0.0000.00%
Post 20:01 ET
8.93MMarket Cap-0.88P/E (TTM)

Alzamend Neuro (ALZN) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Oct 31, 2025
(Q1)Jul 31, 2025
(FY)Apr 30, 2025
(Q4)Apr 30, 2025
(Q3)Jan 31, 2025
(Q2)Oct 31, 2024
(Q1)Jul 31, 2024
(FY)Apr 30, 2024
(Q4)Apr 30, 2024
(Q3)Jan 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-26.51%998.11K
180.57%2.7M
-54.75%4.5M
33.98%1.14M
-61.00%1.04M
-53.20%1.36M
-72.70%962.41K
-33.17%9.94M
-74.28%850.06K
-50.96%2.66M
Selling and administrative expenses
-21.51%821.83K
26.92%959.33K
-11.50%3.08M
3.32%688.78K
-21.42%590.3K
15.70%1.05M
-34.83%755.83K
-53.09%3.48M
-59.77%666.63K
-70.36%751.17K
-Selling and marketing expense
--0
275.00%150K
40.42%347.3K
--3.3K
----
--304K
-83.83%40K
-66.69%247.33K
--0
----
-General and administrative expense
10.61%821.83K
13.06%809.33K
-15.47%2.73M
2.83%685.48K
-21.42%590.3K
-17.90%742.98K
-21.55%715.83K
-51.58%3.24M
-52.71%666.63K
-67.16%751.17K
Research and development costs
-43.33%176.28K
742.75%1.74M
-78.08%1.41M
145.41%450.16K
-76.58%447.11K
-84.42%311.09K
-91.27%206.57K
-13.31%6.46M
-88.87%183.43K
-33.93%1.91M
Operating profit
26.51%-998.11K
-180.57%-2.7M
54.75%-4.5M
-33.98%-1.14M
61.00%-1.04M
53.20%-1.36M
72.70%-962.41K
33.17%-9.94M
74.28%-850.06K
50.96%-2.66M
Net non-operating interest income expense
24.21%-2.65K
79.32%-2.48K
-78.49%-18.03K
65.26%-509
18.85%-2.02K
18.93%-3.5K
-554.28%-12.01K
-31.16%-10.1K
-182.27%-1.47K
-20.66%-2.49K
Non-operating interest expense
-24.21%2.65K
-79.32%2.48K
78.49%18.03K
-65.26%509
-18.85%2.02K
-18.93%3.5K
554.28%12.01K
31.16%10.1K
182.27%1.47K
20.66%2.49K
Other net income (expense)
Income before tax
26.50%-1M
-177.37%-2.7M
54.61%-4.51M
-33.81%-1.14M
60.96%-1.04M
53.15%-1.36M
72.38%-974.41K
33.14%-9.95M
74.24%-851.53K
50.93%-2.66M
Income tax
Net income
26.50%-1M
-177.37%-2.7M
54.61%-4.51M
-33.81%-1.14M
60.96%-1.04M
53.15%-1.36M
72.38%-974.41K
33.14%-9.95M
74.24%-851.53K
50.93%-2.66M
Net income continuous Operations
26.50%-1M
-177.37%-2.7M
54.61%-4.51M
-33.81%-1.14M
60.96%-1.04M
53.15%-1.36M
72.38%-974.41K
33.14%-9.95M
74.24%-851.53K
50.93%-2.66M
Minority interest income
Net income attributable to the parent company
26.50%-1M
-177.37%-2.7M
54.61%-4.51M
-33.81%-1.14M
60.96%-1.04M
53.15%-1.36M
72.38%-974.41K
33.14%-9.95M
74.24%-851.53K
50.93%-2.66M
Preferred stock dividends
590.23K
53.65K
Other preferred stock dividends
Net income attributable to common stockholders
29.29%-1M
-177.37%-2.7M
48.68%-5.11M
-103.13%-1.73M
60.96%-1.04M
51.30%-1.42M
72.38%-974.41K
33.14%-9.95M
74.24%-851.53K
50.93%-2.66M
Basic earnings per share
91.69%-0.3
88.79%-1.28
91.45%-11.32
79.14%-2.2211
94.96%-1.71
90.95%-3.61
76.41%-11.42
42.19%-132.33
84.50%-10.65
54.58%-33.93
Diluted earnings per share
91.69%-0.3
88.79%-1.28
91.45%-11.32
79.14%-2.2211
94.96%-1.71
90.95%-3.61
76.41%-11.42
42.19%-132.33
84.50%-10.65
54.58%-33.93
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Oct 31, 2025(Q1)Jul 31, 2025(FY)Apr 30, 2025(Q4)Apr 30, 2025(Q3)Jan 31, 2025(Q2)Oct 31, 2024(Q1)Jul 31, 2024(FY)Apr 30, 2024(Q4)Apr 30, 2024(Q3)Jan 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -26.51%998.11K180.57%2.7M-54.75%4.5M33.98%1.14M-61.00%1.04M-53.20%1.36M-72.70%962.41K-33.17%9.94M-74.28%850.06K-50.96%2.66M
Selling and administrative expenses -21.51%821.83K26.92%959.33K-11.50%3.08M3.32%688.78K-21.42%590.3K15.70%1.05M-34.83%755.83K-53.09%3.48M-59.77%666.63K-70.36%751.17K
-Selling and marketing expense --0275.00%150K40.42%347.3K--3.3K------304K-83.83%40K-66.69%247.33K--0----
-General and administrative expense 10.61%821.83K13.06%809.33K-15.47%2.73M2.83%685.48K-21.42%590.3K-17.90%742.98K-21.55%715.83K-51.58%3.24M-52.71%666.63K-67.16%751.17K
Research and development costs -43.33%176.28K742.75%1.74M-78.08%1.41M145.41%450.16K-76.58%447.11K-84.42%311.09K-91.27%206.57K-13.31%6.46M-88.87%183.43K-33.93%1.91M
Operating profit 26.51%-998.11K-180.57%-2.7M54.75%-4.5M-33.98%-1.14M61.00%-1.04M53.20%-1.36M72.70%-962.41K33.17%-9.94M74.28%-850.06K50.96%-2.66M
Net non-operating interest income expense 24.21%-2.65K79.32%-2.48K-78.49%-18.03K65.26%-50918.85%-2.02K18.93%-3.5K-554.28%-12.01K-31.16%-10.1K-182.27%-1.47K-20.66%-2.49K
Non-operating interest expense -24.21%2.65K-79.32%2.48K78.49%18.03K-65.26%509-18.85%2.02K-18.93%3.5K554.28%12.01K31.16%10.1K182.27%1.47K20.66%2.49K
Other net income (expense)
Income before tax 26.50%-1M-177.37%-2.7M54.61%-4.51M-33.81%-1.14M60.96%-1.04M53.15%-1.36M72.38%-974.41K33.14%-9.95M74.24%-851.53K50.93%-2.66M
Income tax
Net income 26.50%-1M-177.37%-2.7M54.61%-4.51M-33.81%-1.14M60.96%-1.04M53.15%-1.36M72.38%-974.41K33.14%-9.95M74.24%-851.53K50.93%-2.66M
Net income continuous Operations 26.50%-1M-177.37%-2.7M54.61%-4.51M-33.81%-1.14M60.96%-1.04M53.15%-1.36M72.38%-974.41K33.14%-9.95M74.24%-851.53K50.93%-2.66M
Minority interest income
Net income attributable to the parent company 26.50%-1M-177.37%-2.7M54.61%-4.51M-33.81%-1.14M60.96%-1.04M53.15%-1.36M72.38%-974.41K33.14%-9.95M74.24%-851.53K50.93%-2.66M
Preferred stock dividends 590.23K53.65K
Other preferred stock dividends
Net income attributable to common stockholders 29.29%-1M-177.37%-2.7M48.68%-5.11M-103.13%-1.73M60.96%-1.04M51.30%-1.42M72.38%-974.41K33.14%-9.95M74.24%-851.53K50.93%-2.66M
Basic earnings per share 91.69%-0.388.79%-1.2891.45%-11.3279.14%-2.221194.96%-1.7190.95%-3.6176.41%-11.4242.19%-132.3384.50%-10.6554.58%-33.93
Diluted earnings per share 91.69%-0.388.79%-1.2891.45%-11.3279.14%-2.221194.96%-1.7190.95%-3.6176.41%-11.4242.19%-132.3384.50%-10.6554.58%-33.93
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More